ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
President Cam Gallagher sold $238K of Zentalis Pharmaceuticals, Inc.
Sold$237,760
$20.09Price
11,833Shares
−2%Stake
What ZNTL did after the filing
- The stock from Tue, Feb 14 close, $20.06
- −12.3%
- S&P 500, same days
- −2.4%
Measured over 30 trading days, to the Mar 29 close.
Traded Mon, Feb 13. Filed Tue, Feb 14, 2:09 PM ET, during the session. Returns use the Feb 14 close and the Mar 29 close. Not investment advice.